Heart Health Supplements
Europe · 2 shared keywords
Updated
Reviewed by Vidhi Upadhyay
Europe Oral Rehydration Solutions Market Industry Trends and Forecast to 2034: Segmented by (Product, User, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$120.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $212.7 Mn | — | — |
| 2025 (base) | $223.2 Mn | +$10.4 Mn | — |
| 2026 (forecast) | $234.1 Mn | +$10.9 Mn | +4.9% |
| 2027 (forecast) | $245.6 Mn | +$11.5 Mn | +10% |
| 2028 (forecast) | $257.6 Mn | +$12.0 Mn | +15.4% |
| 2029 (forecast) | $270.2 Mn | +$12.6 Mn | +21.1% |
| 2030 (forecast) | $283.5 Mn | +$13.2 Mn | +27% |
| 2031 (forecast) | $297.4 Mn | +$13.9 Mn | +33.2% |
| 2032 (forecast) | $311.9 Mn | +$14.6 Mn | +39.8% |
| 2033 (forecast) | $327.2 Mn | +$15.3 Mn | +46.6% |
| 2034 (forecast) | $343.2 Mn | +$16.0 Mn | +53.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $223.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $343.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 4.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Also called | Oral Rehydration Salts (ORS) |
| Segments | Product, user and distribution channel (see all) |
| Key players | Abbott Laboratories, Johnson & Johnson, Cipla Inc., FDC Limited, Prestige Consumer Healthcare (see all) |
| Regulator in Europe | EMA and EFSASource: European Medicines Agency. Checked 14 Nov 2026.Source: European Food Safety Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Oral rehydration solutions are salt and sugar mixes that treat dehydration from diarrhoea, saving many children's lives.
Key segments of the oral Rehydration Solutions market include product (Powders, Ready-to-Drink and Tablets) and user (Children, Adults and Travelers).
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the oral Rehydration Solutions market.
Digital tools for community health, local manufacturing and public-private partnerships give the oral Rehydration Solutions market room to grow.
Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the oral Rehydration Solutions market.
The oral Rehydration Solutions market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA).[1] In the countries we cover here, medicines are approved by ANSM (France)[2], BfArM (Germany)[3], AIFA (Italy)[4], Ministry of Health (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. EU law sets common rules for food supplements, and the European Food Safety Authority (EFSA) assesses their health claims.[8] In the countries we cover here, supplement rules come from DGCCRF and ANSES (France)[9], BVL (Germany)[10], Ministry of Health (Italy)[11], Rospotrebnadzor (Russia)[12], AESAN (Spain)[13] and FSA (UK)[14].
[1] European Medicines Agency. Checked 14 Nov 2026.
[2] ANSM, French medicines agency. Checked 14 Nov 2026.
[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[4] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.
[5] Ministry of Health of the Russian Federation. Checked 14 Nov 2026.
[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[8] European Food Safety Authority. Checked 14 Nov 2026.
[9] ANSES. Checked 14 Nov 2026.
[10] Federal Office of Consumer Protection and Food Safety (BVL). Checked 14 Nov 2026.
[11] Italian Ministry of Health. Checked 14 Nov 2026.
[12] Rospotrebnadzor. Checked 14 Nov 2026.
[13] Spanish Agency for Food Safety and Nutrition (AESAN). Checked 14 Nov 2026.
[14] Food Standards Agency. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern oral Rehydration Solutions products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Europe.
What doctors and scientists are doing in Oral Rehydration Solutions right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe · 2 shared keywords
Europe · 2 shared keywords
Europe · 2 shared keywords
Europe · 2 shared keywords
Europe · 2 shared keywords
Europe · 2 shared keywords
Medical Devices · Europe
Medical Devices · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Medical Devices · Europe
Healthcare Services · Europe